How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Zinc Gluconate Supplement Market
- By Form: Tablet, Capsule, Powder, Liquid, Gummy
- By Application: Immune Support, Cold and Flu Relief, Skin Health, Wound Healing, Nutritional Supplement
- By End User: Adults, Children, Elderly, Athletes, Pregnant Women
- By Distribution Channel: Pharmacies, Online Retail, Health Food Stores, Supermarkets, Direct Sales
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Tablet leads By Form at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 281 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.170 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.178 →
Full report · locked preview
Everything inside the Zinc Gluconate Supplement Market report
A complete, evidence-based study - 11 chapters and 118 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Form 5
Application 5
End User 5
Distribution Channel 5
Companies profiled
BASF SE
Balchem Corporation
Zhejiang NHU Co. Ltd.
Glanbia Nutritionals
Jungbunzlauer Suisse AG
Prinova Group LLC
ZMC USA Inc.
Nutritional Resources International
Mosselman Group
Zinpro Corporation
Sabinsa Corporation
Jungbunzlauer AG
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Balchem Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Zhejiang NHU Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Glanbia Nutritionals
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Jungbunzlauer Suisse AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Prinova Group LLC
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →ZMC USA Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Nutritional Resources International
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Mosselman Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Zinpro Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Sabinsa Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Jungbunzlauer AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Ambe Phytoextracts Pvt. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Zinc Specialties Pvt. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Jiangsu Jiuding Health Technology Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$8,525M by 2033 · 6.4% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Tablet44.2
- Capsule16.3
- Powder13.3
- Liquid17.3
- Gummy8.9
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,717M → $3,111M · 7.7%
Europe$1,197M → $1,804M · 5.3%
Asia Pacific$1,093M → $1,701M · 5.7%
Latin America$676.5M → $1,087M · 6.1%
Middle East and Africa$520.4M → $948.1M · 7.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.312026
6.332027
6.352028
6.352029
6.362030
6.382031
6.392032
6.412033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- BASF SE16.6
- Balchem Corporation19.2
- Zhejiang NHU Co. Ltd.4.8
- Glanbia Nutritionals9.1
- Jungbunzlauer Suisse AG10.0
- Prinova Group LLC12.2
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Form19.3%
Application21.2%
End User41.7%
Distribution Channel17.8%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America36.0
- Europe20.9
- Asia Pacific19.7
- Latin America12.6
- Middle East and Africa11.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| BASF SE | 81 | 94 | 95 | 90 | 98 | 89 | 91 |
| Balchem Corporation | 82 | 83 | 86 | 91 | 87 | 76 | 84 |
| Zhejiang NHU Co. Ltd. | 80 | 67 | 80 | 85 | 79 | 70 | 77 |
| Glanbia Nutritionals | 59 | 81 | 62 | 67 | 80 | 64 | 69 |
| Jungbunzlauer Suisse AG | 54 | 60 | 65 | 68 | 72 | 64 | 64 |
| Prinova Group LLC | 62 | 49 | 46 | 69 | 56 | 69 | 59 |
| ZMC USA Inc. | 65 | 44 | 50 | 59 | 61 | 44 | 54 |
| Nutritional Resources International | 55 | 46 | 58 | 53 | 46 | 41 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- BASF SE
- Balchem Corporation
- Zhejiang NHU Co. Ltd.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| BASF SE | ◐ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Balchem Corporation | ✓ | ✓ | ◐ | ◐ | ✓ | ◐ |
| Zhejiang NHU Co. Ltd. | ◐ | ◐ | ✓ | ✓ | ◐ | ✓ |
| Glanbia Nutritionals | ◐ | ◐ | − | ◐ | ✓ | ◐ |
| Jungbunzlauer Suisse AG | − | ◐ | ◐ | ✓ | ◐ | − |
| Prinova Group LLC | − | − | − | ✓ | − | ✓ |
| ZMC USA Inc. | − | ◐ | − | − | − | ◐ |
| Nutritional Resources International | ◐ | − | ◐ | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1BASF SE91
2Balchem Corporation84
3Zhejiang NHU Co. Ltd.77
4Glanbia Nutritionals69
5Jungbunzlauer Suisse AG64
6Prinova Group LLC59
7ZMC USA Inc.54
8Nutritional Resources International50
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
BASF SEBalchem Corporation
Challenger2
Strong scale, closing on the leaders.
Zhejiang NHU Co. Ltd.Glanbia Nutritionals
Contender2
Focused players with pockets of strength.
Jungbunzlauer Suisse AGPrinova Group LLC
Niche2
Specialists in a single segment or region.
ZMC USA Inc.Nutritional Resources International
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Form in North America, then scale across Zinc Gluconate Supplement Market — a $67M beachhead inside a $1.28B market.
Beachhead (SOM)$67Mobtainable near-term
Serviceable (SAM)$458Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Tablet
Best fit — highest urgency & budget in Form.
Economic buyer80 fit
Capsule
Strong fit — clear ROI and a fast path to value.
End user67 fit
Powder
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Form in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel27%
Digital / self-serve21%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Form leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Zinc Gluconate Supplement Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified23%
Evaluation13%
Closed-won7%
$16.0KCAC
$87KLTV
5.4:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Zinc Gluconate Supplement Market is a resilient opportunity — $7.57B by 2033, compounding at 5.0%.
TAM · 2025$5.11Btoday
TAM · 2033$7.57Bforecast
CAGR5.0%2027–2033
Cumulative$56.4Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$7.57BTotal addressable market
SAM$3.11BServiceable available market
SOM$544MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.0% CAGR
Demand compounds through 2033, outpacing GDP across Form.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Form moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$7.57BLarge & growingTAM by 2033 at 5.0% CAGR
$3.11BServiceable nowreachable with today’s model
$544MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.90BBear3.3% CAGR
$7.57BBase5.0% CAGR
$9.69BBull6.6% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Zinc Gluconate Supplement Market — a $3.11B market by 2033. Plan: grow share from 8.3% to 16.2%.
Market size · 2033$3.11Btotal addressable
Market CAGR4.0%2027–2033
Target share16.2%from 8.3% today
Revenue ambition$503Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.3% | 16.2% | At risk |
| Revenue | $241M | $503M | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | At risk |
| Gross margin | 32.3% | 44.6% | Behind |
| Customer retention | 88.3% | 92.8% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Form
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Form share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $61M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Form leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAt risk
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Zinc Gluconate Supplement Market conversation — a $3.14B market you can size, segment and defend in minutes.
Market size · 2033$3.14Btotal opportunity
Growth10.1%CAGR to 2033
Addressable buyers1,374+accounts in scope
Typical ROI4.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Form
Goal Grow share in Form
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.7×return on cost, year one
< 4 mopayback period
$97K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
BASF SEBalchem CorporationZhejiang NHU Co. Ltd.Glanbia NutritionalsJungbunzlauer Suisse AGPrinova Group LLCZMC USA Inc.Nutritional Resources International+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Zinc Gluconate Supplement Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Zinc Gluconate Supplement Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Oxyclozanide Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportPharmaceutical Excipients Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportFibrinogen Concentrate Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportVaricella Live Vaccine Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportEmergency And Transport Stretchers Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportUterine Fibroid Embolization Agents Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportHigh Sensitivity C-Reactive Protein Test Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportUsher Syndrome Threapeutics Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportGelatin Peptide Plasma Substitute Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportTyrosine Protein Kinase Receptor TYRO3 Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportTyrosine Protein Kinase Lyn Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportTyrosine Protein Kinase ITK Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.